{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:23:09Z","timestamp":1761708189217},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Crohn's and Colitis"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.crohns.2008.01.005","type":"journal-article","created":{"date-parts":[[2008,3,3]],"date-time":"2008-03-03T20:27:59Z","timestamp":1204576079000},"page":"202-207","source":"Crossref","is-referenced-by-count":30,"title":["Osteoporosis in inflammatory bowel disease"],"prefix":"10.1093","volume":"2","author":[{"given":"Max","family":"Reinshagen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1016\/j.crohns.2008.01.005_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/gut.37.1.71","article-title":"A controlled study of bone mineral density in patients with inflammatory bowel disease","volume":"37","author":"Silvennoinen","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2008.01.005_bib2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/gut.40.2.228","article-title":"Reduced bone density in patients with inflammatory bowel disease","volume":"40","author":"Bjarnason","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2008.01.005_bib3","first-page":"5","article-title":"Pathological bone density in chronic inflammatory bowel diseases-prevalence and risk factors","volume":"37","author":"Von Tirpitz","year":"1999","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.crohns.2008.01.005_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-2796.2000.00582.x","article-title":"Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis","volume":"247","author":"Ardizzone","year":"2000","journal-title":"J Intern Med"},{"key":"10.1016\/j.crohns.2008.01.005_bib5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00054725-200405000-00007","article-title":"Bones and Crohn's: risk factors associated with low bone mineral density in patients with Crohn's disease","volume":"10","author":"Siffledeen","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2008.01.005_bib6","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1136\/gut.29.10.1332","article-title":"Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease","volume":"29","author":"Motley","year":"1988","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2008.01.005_bib7","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/003655299750025903","article-title":"Bone loss in patients with inflammatory bowel disease is less than expected: a follow-up study","volume":"34","author":"Schulte","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.crohns.2008.01.005_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/00365520310007873","article-title":"Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study","volume":"39","author":"Jahnsen","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.crohns.2008.01.005_bib9","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1097\/00042737-200312000-00003","article-title":"Bone density improves with disease remission in patients with inflammatory bowel disease","volume":"15","author":"Reffitt","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.crohns.2008.01.005_bib10","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1053\/gast.2002.34779","article-title":"Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County, Minnesota","volume":"123","author":"Loftus","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2008.01.005_bib11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1542-3565(03)00185-X","article-title":"Risk of fracture in ulcerative colitis: a population-based study from Olmsted County, Minnesota","volume":"1","author":"Loftus","year":"2003","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.crohns.2008.01.005_bib12","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.cgh.2007.02.024","article-title":"Vertebral fractures and role of low bone mineral density in Crohn's disease","volume":"5","author":"Siffledeen","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.crohns.2008.01.005_bib13","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/gut.51.5.654","article-title":"High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease","volume":"51","author":"Klaus","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2008.01.005_bib14","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1046\/j.1365-2036.2002.01317.x","article-title":"Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease","volume":"16","author":"Stockbrugger","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2008.01.005_bib15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00198-003-1548-3","article-title":"Oral glucocorticoid use is associated with an increased risk of fracture","volume":"15","author":"Steinbuch","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.crohns.2008.01.005_bib16","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jbspin.2006.01.017","article-title":"Bone density in young males with recently diagnosed inflammatory bowel disease","volume":"73","author":"Sakellariou","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.crohns.2008.01.005_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2036.1998.00271.x","article-title":"Sex hormone status and bone metabolism in men with Crohn's disease","volume":"12","author":"Robinson","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2008.01.005_bib18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/gut.40.3.313","article-title":"Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study","volume":"40","author":"Jahnsen","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2008.01.005_bib19","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/00042737-200311000-00003","article-title":"Effect of systemic glucocorticoid therapy on bone metabolism and the osteoprotegerin system in patients with active Crohn's disease","volume":"15","author":"von Tirpitz","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.crohns.2008.01.005_bib20","first-page":"268","article-title":"The OPG\/RANKL\/RANK system in metabolic bone diseases","volume":"4","author":"Hofbauer","year":"2004","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.crohns.2008.01.005_bib21","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/gut.2004.044370","article-title":"The RANKL\/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss","volume":"54","author":"Moschen","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2008.01.005_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2796.1998.00246.x","article-title":"Bone mineral density in patients with Crohn's disease during long-term treatment with azathioprine","volume":"243","author":"Floren","year":"1998","journal-title":"J Intern Med"},{"key":"10.1016\/j.crohns.2008.01.005_bib23","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1365-2036.2004.02097.x","article-title":"Effect of antitumour necrosis factor-alpha therapy on bone turnover in patients with active Crohn's disease: a prospective study","volume":"20","author":"Ryan","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2008.01.005_bib24","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1196\/annals.1346.055","article-title":"The effect of anti-TNF-alpha therapy on spinal bone mineral density in patients with Crohn's disease","volume":"1068","author":"Pazianas","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.crohns.2008.01.005_bib25","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/00002281-200307000-00013","article-title":"Mechanisms of glucocorticoid-induced osteoporosis","volume":"15","author":"Canalis","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.crohns.2008.01.005_bib26","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1074\/jbc.M406294200","article-title":"Glucocorticoids inhibit the transcriptional activity of LEF\/TCF in differentiating osteoblasts in a glycogen synthase kinase-3beta-dependent and -independent manner","volume":"280","author":"Smith","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.crohns.2008.01.005_bib27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.bpg.2005.01.002","article-title":"Bones in coeliac disease: diagnosis and treatment","volume":"19","author":"Corazza","year":"2005","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.crohns.2008.01.005_bib28","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1542\/peds.2006-0841","article-title":"Vitamin D status in children and young adults with inflammatory bowel disease","volume":"118","author":"Pappa","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.crohns.2008.01.005_bib29","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1365-2036.2006.02835.x","article-title":"Altered levels of biochemical indices of bone turnover and bone-related vitamins in patients with Crohn's disease and ulcerative colitis","volume":"23","author":"Gilman","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2008.01.005_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2796.1996.420765000.x","article-title":"Relationships between vitamin D, parathyroid hormone and bone mineral density in inflammatory bowel disease","volume":"239","author":"Silvennoinen","year":"1996","journal-title":"J Intern Med"},{"key":"10.1016\/j.crohns.2008.01.005_bib31","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.bone.2006.04.016","article-title":"Vitamin D receptor gene BsmI and TaqI polymorphisms and fracture risk: a meta-analysis","volume":"39","author":"Fang","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.crohns.2008.01.005_bib32","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1359\/jbmr.2000.15.11.2222","article-title":"A TA repeat polymorphism in the estrogen receptor gene is associated with osteoporotic fractures but polymorphisms in the first exon and intron are not","volume":"15","author":"Langdahl","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.crohns.2008.01.005_bib33","first-page":"16","article-title":"Identifying genetic risk factors for osteoporosis","volume":"6","author":"Uitterlinden","year":"2006","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.crohns.2008.01.005_bib34","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1023\/A:1012300609279","article-title":"Genetic determinants of IL-6 expression levels do not influence bone loss in inflammatory bowel disease","volume":"46","author":"Schulte","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.crohns.2008.01.005_bib35","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1136\/gut.2005.064212","article-title":"Influence of IL-6, COL1A1, and VDR gene polymorphisms on bone mineral density in Crohn's disease","volume":"54","author":"Todhunter","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2008.01.005_bib36","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/gut.49.5.644","article-title":"Allelic variation at the interleukin 1beta gene is associated with decreased bone mass in patients with inflammatory bowel diseases","volume":"49","author":"Nemetz","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2008.01.005_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2005-872911","article-title":"Lack of correlation between the vitamin D receptor Fokl start codon polymorphism and bone mineral density in patients with Crohn's disease","volume":"114","author":"Bregenzer","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.crohns.2008.01.005_bib38","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/gme.0b013e31802d976f","article-title":"Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women","volume":"14","author":"Kim","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.crohns.2008.01.005_bib39","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1359\/jbmr.2002.17.7.1245","article-title":"Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures","volume":"17","author":"Langdahl","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.crohns.2008.01.005_bib40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00223-002-2136-9","article-title":"Single nucleotide polymorphisms in the human gene for osteoprotegerin are not related to bone mineral density or fracture in elderly women","volume":"74","author":"Brandstrom","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.crohns.2008.01.005_bib41","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1210\/jc.2003-032054","article-title":"Osteoprotegerin gene polymorphisms in men with coronary artery disease","volume":"89","author":"Soufi","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.crohns.2008.01.005_bib42","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1210\/jc.2002-021063","article-title":"Osteoprotegerin gene polymorphism and the risk of osteoporosis and vascular disease","volume":"87","author":"Hofbauer","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.crohns.2008.01.005_bib43","first-page":"609","article-title":"Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation","volume":"7","author":"Vogelsang","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.crohns.2008.01.005_bib44","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1111\/j.1572-0241.2003.07676.x","article-title":"Lack of relationship of calcium and vitamin D intake to bone mineral density in premenopausal women with inflammatory bowel disease","volume":"98","author":"Bernstein","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2008.01.005_bib45","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1365-2036.2003.01794.x","article-title":"A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease","volume":"18","author":"Bartram","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2008.01.005_bib46","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1046\/j.1365-2036.2003.01448.x","article-title":"Therapy of osteoporosis in patients with Crohn's disease: a randomized study comparing sodium fluoride and ibandronate","volume":"17","author":"von Tirpitz","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2008.01.005_bib47","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1542-3565(04)00663-9","article-title":"Randomized trial of etidronate plus calcium and vitamin D for treatment of low bone mineral density in Crohn's disease","volume":"3","author":"Siffledeen","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.crohns.2008.01.005_bib48","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/00365520500206467","article-title":"Intravenous pamidronate in combination with calcium and vitamin D: highly effective in the treatment of low bone mineral density in inflammatory bowel disease","volume":"41","author":"Stokkers","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.crohns.2008.01.005_bib49","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1572-0241.2006.00372.x","article-title":"A double-blind placebo-controlled study of the effects of the bisphosphonate risedronate on bone mass in patients with inflammatory bowel disease","volume":"101","author":"Henderson","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2008.01.005_bib50","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00198-005-1927-z","article-title":"Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease","volume":"16","author":"Palomba","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.crohns.2008.01.005_bib51","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1053\/gast.2000.16518","article-title":"Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease","volume":"119","author":"Haderslev","year":"2000","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1016\/j.crohns.2008.01.005_bib52","doi-asserted-by":"crossref","first-page":"i36","DOI":"10.1136\/gut.2005.081950c","article-title":"European evidence based consensus on the diagnosis and management of Crohn's disease: special situations","volume":"55","author":"Caprilli","year":"2006","journal-title":"Gut"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994608000081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994608000081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/2\/3\/202\/7799187\/2-3-202.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T01:55:16Z","timestamp":1503453316000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1016\/j.crohns.2008.01.005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S1873994608000081"],"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2008.01.005","relation":{},"ISSN":["1873-9946"],"issn-type":[{"value":"1873-9946","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}